Fernando Martin Burrieza | European Respiratory Society (original) (raw)
Papers by Fernando Martin Burrieza
The European respiratory journal, Apr 1, 2016
The modern research environment is much more complex and challenging than before [1]. Mechanistic... more The modern research environment is much more complex and challenging than before [1]. Mechanistic research has become increasingly sophisticated and specialised, while new clinical research approaches have vastly increased the amount of data generated. These new developments bring a number of challenges. The first challenge is collecting and analysing the current deluge of data. This requires more than just one laboratory group, one institution or one national institute. Today's research requires the coordination of wide ranging expertise that is often only available on the international or even global level. A second challenge involves the increased availability of patient data, which has raised concerns about privacy of personal data resulting in new legal and regulatory constraints for handling personal data in a multinational and multicultural environment, making large-scale clinical research even more complicated. A third challenge is that, currently, the greatest economic burden in healthcare comes from chronic, noncommunicable disease [2]. Natural history studies requiring timescales measured in decades are needed if this burden is to be reduced. However, natural history studies are not only difficult to conduct, but they are also challenging because most research funding is for time periods of 3-5 years while studies of 10 years or longer are needed. Finally, a fourth challenge is difficulty in obtaining funding for respiratory research. Obtaining funding at a European level has always been difficult because of competition from other areas and because of the complex policies and procedures. The Horizon 2020 programme represents a great opportunity for increasing respiratory research, but the competition appears to be ever fiercer. There is also a perception that on a national level all research funding is becoming ever more difficult to obtain [3, 4]. Thus, today's translational researchers face many challenges, including more difficult and complex European regulations [5], and have a number of unfulfilled needs. In order to help researchers meet these needs, medical societies such as the European Respiratory Society (ERS) could assist to coordinate multinational research efforts [1]. In 2013, the ERS Leadership formulated a strategy for the following 5 years that aimed to serve ERS members better and further support the overall mission of the ERS, taking into account changes occurring both within the ERS and within the respiratory field. The fourth of the eight agreed decisions,
European Respiratory Journal, 2016
The modern research environment is much more complex and challenging than before [1]. Mechanistic... more The modern research environment is much more complex and challenging than before [1]. Mechanistic research has become increasingly sophisticated and specialised, while new clinical research approaches have vastly increased the amount of data generated. These new developments bring a number of challenges. The first challenge is collecting and analysing the current deluge of data. This requires more than just one laboratory group, one institution or one national institute. Today's research requires the coordination of wide ranging expertise that is often only available on the international or even global level. A second challenge involves the increased availability of patient data, which has raised concerns about privacy of personal data resulting in new legal and regulatory constraints for handling personal data in a multinational and multicultural environment, making large-scale clinical research even more complicated. A third challenge is that, currently, the greatest economic burden in healthcare comes from chronic, noncommunicable disease [2]. Natural history studies requiring timescales measured in decades are needed if this burden is to be reduced. However, natural history studies are not only difficult to conduct, but they are also challenging because most research funding is for time periods of 3-5 years while studies of 10 years or longer are needed. Finally, a fourth challenge is difficulty in obtaining funding for respiratory research. Obtaining funding at a European level has always been difficult because of competition from other areas and because of the complex policies and procedures. The Horizon 2020 programme represents a great opportunity for increasing respiratory research, but the competition appears to be ever fiercer. There is also a perception that on a national level all research funding is becoming ever more difficult to obtain [3, 4]. Thus, today's translational researchers face many challenges, including more difficult and complex European regulations [5], and have a number of unfulfilled needs. In order to help researchers meet these needs, medical societies such as the European Respiratory Society (ERS) could assist to coordinate multinational research efforts [1]. In 2013, the ERS Leadership formulated a strategy for the following 5 years that aimed to serve ERS members better and further support the overall mission of the ERS, taking into account changes occurring both within the ERS and within the respiratory field. The fourth of the eight agreed decisions,
The European respiratory journal, 2016
strategic plan to serve its members better and achieve its mission objectives (table 1) [1]. The ... more strategic plan to serve its members better and achieve its mission objectives (table 1) [1]. The outcomes of the previous 2006-2007 Strategy Meeting [2] summarising the ERS pillars (figure 1) and the recently published ERS Presidential plans were used as background material [3-5]. The mid-term strategy implementation review was held on October 21, 2015 in Amsterdam, The Netherlands. It involved the ERS Leadership represented by the members of the Management Group (figure 2), the body that replaced the previous Steering Committee as per the newly approved ERS Constitution and Bylaws [6, 7],
European Respiratory Journal, 2016
strategic plan to serve its members better and achieve its mission objectives (table 1) [1]. The ... more strategic plan to serve its members better and achieve its mission objectives (table 1) [1]. The outcomes of the previous 2006-2007 Strategy Meeting [2] summarising the ERS pillars (figure 1) and the recently published ERS Presidential plans were used as background material [3-5]. The mid-term strategy implementation review was held on October 21, 2015 in Amsterdam, The Netherlands. It involved the ERS Leadership represented by the members of the Management Group (figure 2), the body that replaced the previous Steering Committee as per the newly approved ERS Constitution and Bylaws [6, 7],
![Research paper thumbnail of [Spanish Society of Cardiology ethical framework (executive summary)]](https://attachments.academia-assets.com/74964257/thumbnails/1.jpg)
](Revista Espa De Cardiologia, 2007
The full document includes a large glossary of terms and can be found at www.secardiologia.es: th... more The full document includes a large glossary of terms and can be found at www.secardiologia.es: the consultants who offered suggestions and comments is listed there. The SEC would like to publicly thank all of them. The authors declare that they have not received any financial support, have not experienced any conflicts of interest before, during, or after preparing the document and have carried out the task with full autonomy.
![Research paper thumbnail of [The scope of cardiological competence in the new clinical settings. Spanish Society of Cardiology consensus document]](https://attachments.academia-assets.com/74964263/thumbnails/1.jpg)
](Revista Espa de Cardiologia
The European respiratory journal, 2014
The European Respiratory Society (ERS), in order to serve better its members and achieve its miss... more The European Respiratory Society (ERS), in order to serve better its members and achieve its mission objectives (table 1) [1], organised a Strategy Meeting to plan its core strategic priorities for the period 2013-2018, taking into account changes occurring both within the society and within the respiratory field in Europe and beyond. This meeting was held on July 3 and 4, 2013 in Lausanne, Switzerland to formulate future directions. We took into account the Executive Summary of the 2006-2007 Strategy Meeting [2] summarising the ERS pillars (fig. 1) and the recently published ERS Presidential plans as an operational guide [3-5]. The Strategy Meeting involved the ERS Leadership represented by the members of the Steering Committee (fig. 2). It was prepared by an ad hoc meeting preceding the event, involving the Past President and the Secretary General Elect (the officers designated to act as chair and moderator), as well as the Executive Director and the Head of the Executive Office. This was used as the starting point to develop the strategic meeting agenda. Participants were encouraged to express their opinions freely and to think ''outside the box'' in order to bring fresh ideas to the table. Whilst the focus of the exercise was definitely the future,
Revista Española de Cardiología (English Edition), 2006
The full document includes a large glossary of terms and can be found at www.secardiologia.es: th... more The full document includes a large glossary of terms and can be found at www.secardiologia.es: the consultants who offered suggestions and comments is listed there. The SEC would like to publicly thank all of them. The authors declare that they have not received any financial support, have not experienced any conflicts of interest before, during, or after preparing the document and have carried out the task with full autonomy.
Revista Española de Cardiología, 2006
... Marco ético de la Sociedad Española de Cardiología (versión resumida) Manuel de los Reyes Lóp... more ... Marco ético de la Sociedad Española de Cardiología (versión resumida) Manuel de los Reyes Lópeza, Cándido Martín Luengob, Josep Brugada Terradellasc, Ginés Sanz Romeroc, RosaMaría Lidón Corbíd y Fernando Martín Burriezae aComisión de Asesoría Ética. ...
Revista Española de Cardiología, 2008
Escaned Barbosa J et al. Ámbito de actuación de la cardiología en los nuevos escenarios clínicos
Revista Española de Cardiología (English Edition), 2008
Revista Española de Cardiología (English Edition), 2009
The publication of research articles has increased considerably in recent years in all biomedical... more The publication of research articles has increased considerably in recent years in all biomedical fields. The present study examines the position of Spanish quality research in cardiology in the European and world context, and its evolution during the 5-year period 2003-2007. Using the Science Citation Index Expanded of Thomson Reuters as data source, we compared Spanish cardiovascular scientific production with that of the rest of countries in the European Union and of the most important countries worldwide, along with relative productivity as per number of inhabitants and Gross Domestic Product, and the number of citations in the journals of the <Cardiac and Cardiovascular Systems> area of the Journal Citation Reports (CCS-JCR). Spain ranks sixth in the European Union and ninth worldwide in scientific production (tenth worldwide if only the journals of the first quartile of the CCS-JCR area are considered). As regards the number of citations received, Spain ranks seventh in the European Union and eleventh worldwide. In terms of relative productivity as per number of inhabitants and Gross Domestic Product, the Spanish ranking is less favorable (positions 15 and 18, respectively). The ranking of Spanish cardiovascular research is similar to that of other biomedical fields, though its position is less favorable in relation to certain demographic and economical indicators. In order to maintain adequate investigational levels, it is necessary for the European governments and scientific societies to regard the promotion of high-quality cardiological research as a priority concern.
European Respiratory Journal, 2014
The European Respiratory Society (ERS), in order to serve better its members and achieve its miss... more The European Respiratory Society (ERS), in order to serve better its members and achieve its mission objectives (table 1) [1], organised a Strategy Meeting to plan its core strategic priorities for the period 2013-2018, taking into account changes occurring both within the society and within the respiratory field in Europe and beyond. This meeting was held on July 3 and 4, 2013 in Lausanne, Switzerland to formulate future directions. We took into account the Executive Summary of the 2006-2007 Strategy Meeting [2] summarising the ERS pillars (fig. 1) and the recently published ERS Presidential plans as an operational guide [3-5]. The Strategy Meeting involved the ERS Leadership represented by the members of the Steering Committee (fig. 2). It was prepared by an ad hoc meeting preceding the event, involving the Past President and the Secretary General Elect (the officers designated to act as chair and moderator), as well as the Executive Director and the Head of the Executive Office. This was used as the starting point to develop the strategic meeting agenda. Participants were encouraged to express their opinions freely and to think ''outside the box'' in order to bring fresh ideas to the table. Whilst the focus of the exercise was definitely the future,
Rev Esp Cardiol, 2008
Escaned Barbosa J et al. Ámbito de actuación de la cardiología en los nuevos escenarios clínicos
The publication of research articles has increased considerably in recent years in all biomedical... more The publication of research articles has increased considerably in recent years in all biomedical fields. The present study examines the position of Spanish quality research in cardiology in the European and world context, and its evolution during the 5-year period 2003-2007. Using the Science Citation Index Expanded of Thomson Reuters as data source, we compared Spanish cardiovascular scientific production with that of the rest of countries in the European Union and of the most important countries worldwide, along with relative productivity as per number of inhabitants and Gross Domestic Product, and the number of citations in the journals of the <Cardiac and Cardiovascular Systems> area of the Journal Citation Reports (CCS-JCR). Spain ranks sixth in the European Union and ninth worldwide in scientific production (tenth worldwide if only the journals of the first quartile of the CCS-JCR area are considered). As regards the number of citations received, Spain ranks seventh in the European Union and eleventh worldwide. In terms of relative productivity as per number of inhabitants and Gross Domestic Product, the Spanish ranking is less favorable (positions 15 and 18, respectively). The ranking of Spanish cardiovascular research is similar to that of other biomedical fields, though its position is less favorable in relation to certain demographic and economical indicators. In order to maintain adequate investigational levels, it is necessary for the European governments and scientific societies to regard the promotion of high-quality cardiological research as a priority concern.
Cell, 2006
... Marco ético de la Sociedad Española de Cardiología (versión resumida) Manuel de los Reyes Lóp... more ... Marco ético de la Sociedad Española de Cardiología (versión resumida) Manuel de los Reyes Lópeza, Cándido Martín Luengob, Josep Brugada Terradellasc, Ginés Sanz Romeroc, RosaMaría Lidón Corbíd y Fernando Martín Burriezae aComisión de Asesoría Ética. ...
The European respiratory journal, Apr 1, 2016
The modern research environment is much more complex and challenging than before [1]. Mechanistic... more The modern research environment is much more complex and challenging than before [1]. Mechanistic research has become increasingly sophisticated and specialised, while new clinical research approaches have vastly increased the amount of data generated. These new developments bring a number of challenges. The first challenge is collecting and analysing the current deluge of data. This requires more than just one laboratory group, one institution or one national institute. Today's research requires the coordination of wide ranging expertise that is often only available on the international or even global level. A second challenge involves the increased availability of patient data, which has raised concerns about privacy of personal data resulting in new legal and regulatory constraints for handling personal data in a multinational and multicultural environment, making large-scale clinical research even more complicated. A third challenge is that, currently, the greatest economic burden in healthcare comes from chronic, noncommunicable disease [2]. Natural history studies requiring timescales measured in decades are needed if this burden is to be reduced. However, natural history studies are not only difficult to conduct, but they are also challenging because most research funding is for time periods of 3-5 years while studies of 10 years or longer are needed. Finally, a fourth challenge is difficulty in obtaining funding for respiratory research. Obtaining funding at a European level has always been difficult because of competition from other areas and because of the complex policies and procedures. The Horizon 2020 programme represents a great opportunity for increasing respiratory research, but the competition appears to be ever fiercer. There is also a perception that on a national level all research funding is becoming ever more difficult to obtain [3, 4]. Thus, today's translational researchers face many challenges, including more difficult and complex European regulations [5], and have a number of unfulfilled needs. In order to help researchers meet these needs, medical societies such as the European Respiratory Society (ERS) could assist to coordinate multinational research efforts [1]. In 2013, the ERS Leadership formulated a strategy for the following 5 years that aimed to serve ERS members better and further support the overall mission of the ERS, taking into account changes occurring both within the ERS and within the respiratory field. The fourth of the eight agreed decisions,
European Respiratory Journal, 2016
The modern research environment is much more complex and challenging than before [1]. Mechanistic... more The modern research environment is much more complex and challenging than before [1]. Mechanistic research has become increasingly sophisticated and specialised, while new clinical research approaches have vastly increased the amount of data generated. These new developments bring a number of challenges. The first challenge is collecting and analysing the current deluge of data. This requires more than just one laboratory group, one institution or one national institute. Today's research requires the coordination of wide ranging expertise that is often only available on the international or even global level. A second challenge involves the increased availability of patient data, which has raised concerns about privacy of personal data resulting in new legal and regulatory constraints for handling personal data in a multinational and multicultural environment, making large-scale clinical research even more complicated. A third challenge is that, currently, the greatest economic burden in healthcare comes from chronic, noncommunicable disease [2]. Natural history studies requiring timescales measured in decades are needed if this burden is to be reduced. However, natural history studies are not only difficult to conduct, but they are also challenging because most research funding is for time periods of 3-5 years while studies of 10 years or longer are needed. Finally, a fourth challenge is difficulty in obtaining funding for respiratory research. Obtaining funding at a European level has always been difficult because of competition from other areas and because of the complex policies and procedures. The Horizon 2020 programme represents a great opportunity for increasing respiratory research, but the competition appears to be ever fiercer. There is also a perception that on a national level all research funding is becoming ever more difficult to obtain [3, 4]. Thus, today's translational researchers face many challenges, including more difficult and complex European regulations [5], and have a number of unfulfilled needs. In order to help researchers meet these needs, medical societies such as the European Respiratory Society (ERS) could assist to coordinate multinational research efforts [1]. In 2013, the ERS Leadership formulated a strategy for the following 5 years that aimed to serve ERS members better and further support the overall mission of the ERS, taking into account changes occurring both within the ERS and within the respiratory field. The fourth of the eight agreed decisions,
The European respiratory journal, 2016
strategic plan to serve its members better and achieve its mission objectives (table 1) [1]. The ... more strategic plan to serve its members better and achieve its mission objectives (table 1) [1]. The outcomes of the previous 2006-2007 Strategy Meeting [2] summarising the ERS pillars (figure 1) and the recently published ERS Presidential plans were used as background material [3-5]. The mid-term strategy implementation review was held on October 21, 2015 in Amsterdam, The Netherlands. It involved the ERS Leadership represented by the members of the Management Group (figure 2), the body that replaced the previous Steering Committee as per the newly approved ERS Constitution and Bylaws [6, 7],
European Respiratory Journal, 2016
strategic plan to serve its members better and achieve its mission objectives (table 1) [1]. The ... more strategic plan to serve its members better and achieve its mission objectives (table 1) [1]. The outcomes of the previous 2006-2007 Strategy Meeting [2] summarising the ERS pillars (figure 1) and the recently published ERS Presidential plans were used as background material [3-5]. The mid-term strategy implementation review was held on October 21, 2015 in Amsterdam, The Netherlands. It involved the ERS Leadership represented by the members of the Management Group (figure 2), the body that replaced the previous Steering Committee as per the newly approved ERS Constitution and Bylaws [6, 7],
Revista Espa De Cardiologia, 2007
The full document includes a large glossary of terms and can be found at www.secardiologia.es: th... more The full document includes a large glossary of terms and can be found at www.secardiologia.es: the consultants who offered suggestions and comments is listed there. The SEC would like to publicly thank all of them. The authors declare that they have not received any financial support, have not experienced any conflicts of interest before, during, or after preparing the document and have carried out the task with full autonomy.
Revista Espa de Cardiologia
The European respiratory journal, 2014
The European Respiratory Society (ERS), in order to serve better its members and achieve its miss... more The European Respiratory Society (ERS), in order to serve better its members and achieve its mission objectives (table 1) [1], organised a Strategy Meeting to plan its core strategic priorities for the period 2013-2018, taking into account changes occurring both within the society and within the respiratory field in Europe and beyond. This meeting was held on July 3 and 4, 2013 in Lausanne, Switzerland to formulate future directions. We took into account the Executive Summary of the 2006-2007 Strategy Meeting [2] summarising the ERS pillars (fig. 1) and the recently published ERS Presidential plans as an operational guide [3-5]. The Strategy Meeting involved the ERS Leadership represented by the members of the Steering Committee (fig. 2). It was prepared by an ad hoc meeting preceding the event, involving the Past President and the Secretary General Elect (the officers designated to act as chair and moderator), as well as the Executive Director and the Head of the Executive Office. This was used as the starting point to develop the strategic meeting agenda. Participants were encouraged to express their opinions freely and to think ''outside the box'' in order to bring fresh ideas to the table. Whilst the focus of the exercise was definitely the future,
Revista Española de Cardiología (English Edition), 2006
The full document includes a large glossary of terms and can be found at www.secardiologia.es: th... more The full document includes a large glossary of terms and can be found at www.secardiologia.es: the consultants who offered suggestions and comments is listed there. The SEC would like to publicly thank all of them. The authors declare that they have not received any financial support, have not experienced any conflicts of interest before, during, or after preparing the document and have carried out the task with full autonomy.
Revista Española de Cardiología, 2006
... Marco ético de la Sociedad Española de Cardiología (versión resumida) Manuel de los Reyes Lóp... more ... Marco ético de la Sociedad Española de Cardiología (versión resumida) Manuel de los Reyes Lópeza, Cándido Martín Luengob, Josep Brugada Terradellasc, Ginés Sanz Romeroc, RosaMaría Lidón Corbíd y Fernando Martín Burriezae aComisión de Asesoría Ética. ...
Revista Española de Cardiología, 2008
Escaned Barbosa J et al. Ámbito de actuación de la cardiología en los nuevos escenarios clínicos
Revista Española de Cardiología (English Edition), 2008
Revista Española de Cardiología (English Edition), 2009
The publication of research articles has increased considerably in recent years in all biomedical... more The publication of research articles has increased considerably in recent years in all biomedical fields. The present study examines the position of Spanish quality research in cardiology in the European and world context, and its evolution during the 5-year period 2003-2007. Using the Science Citation Index Expanded of Thomson Reuters as data source, we compared Spanish cardiovascular scientific production with that of the rest of countries in the European Union and of the most important countries worldwide, along with relative productivity as per number of inhabitants and Gross Domestic Product, and the number of citations in the journals of the <Cardiac and Cardiovascular Systems> area of the Journal Citation Reports (CCS-JCR). Spain ranks sixth in the European Union and ninth worldwide in scientific production (tenth worldwide if only the journals of the first quartile of the CCS-JCR area are considered). As regards the number of citations received, Spain ranks seventh in the European Union and eleventh worldwide. In terms of relative productivity as per number of inhabitants and Gross Domestic Product, the Spanish ranking is less favorable (positions 15 and 18, respectively). The ranking of Spanish cardiovascular research is similar to that of other biomedical fields, though its position is less favorable in relation to certain demographic and economical indicators. In order to maintain adequate investigational levels, it is necessary for the European governments and scientific societies to regard the promotion of high-quality cardiological research as a priority concern.
European Respiratory Journal, 2014
The European Respiratory Society (ERS), in order to serve better its members and achieve its miss... more The European Respiratory Society (ERS), in order to serve better its members and achieve its mission objectives (table 1) [1], organised a Strategy Meeting to plan its core strategic priorities for the period 2013-2018, taking into account changes occurring both within the society and within the respiratory field in Europe and beyond. This meeting was held on July 3 and 4, 2013 in Lausanne, Switzerland to formulate future directions. We took into account the Executive Summary of the 2006-2007 Strategy Meeting [2] summarising the ERS pillars (fig. 1) and the recently published ERS Presidential plans as an operational guide [3-5]. The Strategy Meeting involved the ERS Leadership represented by the members of the Steering Committee (fig. 2). It was prepared by an ad hoc meeting preceding the event, involving the Past President and the Secretary General Elect (the officers designated to act as chair and moderator), as well as the Executive Director and the Head of the Executive Office. This was used as the starting point to develop the strategic meeting agenda. Participants were encouraged to express their opinions freely and to think ''outside the box'' in order to bring fresh ideas to the table. Whilst the focus of the exercise was definitely the future,
Rev Esp Cardiol, 2008
Escaned Barbosa J et al. Ámbito de actuación de la cardiología en los nuevos escenarios clínicos
The publication of research articles has increased considerably in recent years in all biomedical... more The publication of research articles has increased considerably in recent years in all biomedical fields. The present study examines the position of Spanish quality research in cardiology in the European and world context, and its evolution during the 5-year period 2003-2007. Using the Science Citation Index Expanded of Thomson Reuters as data source, we compared Spanish cardiovascular scientific production with that of the rest of countries in the European Union and of the most important countries worldwide, along with relative productivity as per number of inhabitants and Gross Domestic Product, and the number of citations in the journals of the <Cardiac and Cardiovascular Systems> area of the Journal Citation Reports (CCS-JCR). Spain ranks sixth in the European Union and ninth worldwide in scientific production (tenth worldwide if only the journals of the first quartile of the CCS-JCR area are considered). As regards the number of citations received, Spain ranks seventh in the European Union and eleventh worldwide. In terms of relative productivity as per number of inhabitants and Gross Domestic Product, the Spanish ranking is less favorable (positions 15 and 18, respectively). The ranking of Spanish cardiovascular research is similar to that of other biomedical fields, though its position is less favorable in relation to certain demographic and economical indicators. In order to maintain adequate investigational levels, it is necessary for the European governments and scientific societies to regard the promotion of high-quality cardiological research as a priority concern.
Cell, 2006
... Marco ético de la Sociedad Española de Cardiología (versión resumida) Manuel de los Reyes Lóp... more ... Marco ético de la Sociedad Española de Cardiología (versión resumida) Manuel de los Reyes Lópeza, Cándido Martín Luengob, Josep Brugada Terradellasc, Ginés Sanz Romeroc, RosaMaría Lidón Corbíd y Fernando Martín Burriezae aComisión de Asesoría Ética. ...